Drugs for which variability in the log2(MIC) data from the two sample processing approaches was sufficient to perform the statistical equivalence testing |
|
|
|
Aminoglycosides |
-Mycins |
No |
Tobramycin |
β-Lactams |
Penicillins, including amino-, carboxy-, and ureido- |
No |
Ampicillin |
|
Penicillins, including amino-, carboxy-, and ureido-, with β-lactamase inhibitors |
Yes |
Ampicillin with sulbactam, 2:1 ratio |
|
Cephems |
No |
Cefazolin |
|
|
No |
Ceftiofur |
Macrolides |
Macrolides |
No |
Tilmicosin |
|
Triamilides |
No |
Tulathromycin |
Phenicols |
NA |
No |
Florfenicol |
Tetracyclines |
Tetracyclines |
No |
Chlortetracycline |
|
|
No |
Minocycline |
|
|
No |
Oxytetracycline |
|
|
No |
Tetracycline |
Drugs for which variability in the log2(MIC) data from the two sample processing approaches was insufficient to perform the statistical equivalence testing |
|
|
|
Aminoglycosides |
-Micins |
No |
Amikacin |
|
|
No |
Gentamicin |
|
-Mycins |
No |
Neomycin |
|
|
No |
Spectinomycin |
β-Lactams |
Penicillins, including amino-, carboxy-, and ureido- |
No |
Penicillin |
|
No |
Piperacillin |
|
Penicillins, including amino-, carboxy-, and ureido-, with β-lactamase inhibitors |
Yes |
Piperacillin with tazobactam constant |
|
Yes |
Ticarcillin with clavulanic acid |
|
Carbapenems |
No |
Doripenem |
|
|
No |
Ertapenem |
|
|
No |
Imipenem |
|
|
No |
Meropenem |
|
Monobactams |
No |
Aztreonam |
|
Cephems |
No |
Cefepime |
|
|
No |
Ceftazidime |
|
|
No |
Ceftriaxone |
Macrolides |
Macrolides |
No |
Tylosin |
Nitrofurans |
NA |
No |
Nitrofurantoin |
Pleuromutilins |
NA |
No |
Pleuromutilin |
|
|
No |
Tiamulin |
Lincosamides |
NA |
No |
Clindamycin |
Quinolones |
Quinolones |
No |
Nalidixic acid |
|
Fluoroquinolones |
No |
Ciprofloxacin |
|
|
No |
Danofloxacin |
|
|
No |
Enrofloxacin |
|
|
No |
Levofloxacin |
Sulfonamides |
NA |
No |
Sulfadimethoxine |
|
|
Yes |
Sulfamethoxazole with trimethoprim |
Tetracyclines |
Glycylcyclines |
No |
Tigecycline |